Shares of Medplus Health Services Ltd gained almost 4% on 26 February despite the company’s subsidiary receiving a suspension order from the Drugs and Control Authorities of Mahabubnagar, Telangana.

The assistant director of Drugs Control Administration, Mahabubnagar, Telangana, has issued a temporary suspension of drug licence for nine days for a store at Wanaparthy, Mahabubnagar.

Earlier in February, the Thane Food and Drug Administration suspended the drug licence for the store in Khopat Thane for 15 days for violation of various conditions.

In January, the company received orders from the assistant director and drug sales licensing authority of the Drug Control Administration, Mahabubnagar TS, suspending the licence of a store at Shankarpally Jadcherla for six days and another suspension of licence for seven days for a store at HayathNagar.

The shares of the company touched a 52-week high of Rs 977.45 on 31 July 2023 and a 52-week low of Rs 597.95 on 14 February 2024.

At 3:30 pm, the shares of Medplus Health closed 0.92% higher at Rs 695.25 on NSE.